Filspari Granted Accelerated Approval to Reduce Proteinuria in IgA Nephropathy
Sparsentan is an endothelin and angiotensin II receptor antagonist.
Diagnosis & Disease Information
What Do We Know About Cancer Risk in Patients With Anemia?
Patients with anemia may know some of the risks associated with the condition, but do they know about potential cancer-related risks? How can health care professionals educate patients on the risks, and what is known about the potential association between newly diagnosed anemia and cancer risk?
It Is Time for Nephrology Practices to Bolster Their Nutrition Care
Practices need to look at all opportunities for preserving kidney function, according to the director of the Kidney Nutrition Institute.
Nephrologists Lag Behind Other Physicians in Prescribing SGLT2 Inhibitors
In the final 12 months of a 7-year study period (January 2015 to April 2022), endocrinologists accounted for 11-fold more SGLT2 inhibitor prescriptions than nephrologists, investigators report.
FDA Needs Additional Time to Review Sparsentan, Tofersen Applications
The target action dates have been extended by 3 months to allow for extra time to review the applications.
Oxlumo Indication Expanded to Include Patients With Advanced PH1
The approval was based on data from the phase 3 ILLUMINATE-C study that included 21 dialysis-independent and -dependent patients with PH1.
The Rise of Advanced Practitioners in Nephrology and Urology
Advanced practitioners providers such as nurse practitioners and physician assistants play an increasingly important role in nephrology and urology practices.
Therapeutic Peptide Granted Orphan Drug Status for Hepatorenal Syndrome
The Company is currently evaluating OCE-205 in a phase 2 trial in adults who have developed hepatorenal syndrome with acute kidney injury.
Study Finds Low Nephrology Referral Rate for High-Risk CKD
Even patients at the highest risk for kidney failure had inadequate nephrology referral, a study found.
Study: Women Less Likely to Receive Appropriate CKD Care
Even women meeting objective criteria for CKD and nephrology referral were disadvantaged, according to investigators.
- Loading...
Loading...
Next post in Chronic Kidney Disease (CKD)
Loading... 
Loading...